Somani A, Ibrahim S, Tassavor M, Yoo J, Farberg A. Use of the 40-Gene Expression Profile (40-GEP) Test in Medicare-Eligible Patients Diagnosed with Cutaneous Squamous Cell Carcinoma (cSCC) to Guide Adjuvant Radiation Therapy (ART) Decisions Leads to a Significant Reduction in Healthcare Costs . J of Skin [Internet]. 2024Jan.16 [cited 2024Jul.3];8(1):s336. Available from: https://jofskin.org/index.php/skin/article/view/2460